SR One's Simeon George on recent news from CRISPR, Turning Point (Bristol), Arcellx, and more
Simeon George talks about his firm's philosophy, advice for biotech entrepreneurs, and discusses Turning Point, Avenzo, CRISPR, Nkarta, Arcellx, ADARx, and Rezo Therapeutics.